Company Overview

Update
Founded:
2010
Founders:
Shankar Musunuri
Headquarters:
Exton, PA
Funding:
$52.7M
Categories:
Biotechnology
Description:
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.

Detailed Description

Update

Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.

Current Team (4)

Update

Funding Rounds (2) - $52.7M

Update

Offices/Locations (1)

Update
  • Office

    1 East Uwchlan Avenue

    Suite 302

    Exton, PA 19341

    USA

News (2)

Update